Inhibrx Biosciences, Inc. announced a private placement that it has issued 1,838 shares of common stock and warrants to purchase 7,354 shares of common stock at a per share exercise price of $17 per share on May 29, 2024. The transaction will include participation from new investor, Oxford Finance LLC.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.56 USD | -1.31% |
|
-10.14% | 0.00% |
06-24 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
05-30 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) added to S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 196M | |
+2.88% | 93.97B | |
+6.58% | 41.61B | |
-13.71% | 33.32B | |
+77.12% | 28.8B | |
-16.18% | 15.61B | |
-8.28% | 13.27B | |
-12.49% | 11.46B | |
+162.44% | 10.06B | |
-54.92% | 9.09B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx Biosciences, Inc.
- Inhibrx Biosciences, Inc. announced that it has received funding from Oxford Finance LLC